Autoimmune aspects of premature ovarian failure;Avtoimunski vidiki prezgodnje menopavze

Zdravniski Vestnik

Volumn 78, Issue SUPPL. 1, 2009, Pages

  Meden Vrtovec, Helena ^a   Levičnik, Alenka ^a   Ihan, Alojz ^b   Vizjak, Alenka ^b  

^a Univerzitetni klinični center Ljubljana ^*  (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Antiovarian antibodies; Antithyroid antibodies; Premature ovarian failure; T lymphocytes abnormalities

Indexed keywords

EID: 79951938966     PISSN: 13180347     EISSN: 15810224     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Conway GS. Premature ovarian failure. Br Med Bull 1999; 56: 643-9.
2. Anasti IN. Premature ovarian failure: an update. Fertil Steril 1998; 70: 1-15.
3. Taylor AE. Systemic adversities of ovarian failure. J Soc Gynecol Investig 2001; 8: S7-S9.
4. Snowdown DA, Kane RL, Beeson WL, Burke GL, Sprafka SM, Potter J, et al. Is early natural menopause a biologic marker of health and aging? Am J Public Health 1989; 79: 709-14. (Pubitemid 19142908)
5. Conway GS, Kaltsas G, Patel A, Davies MS, Jocobs HS. Characterisation of idiopathic premature ovarian failure. Fertil Steril 1996; 65: 337-41. (Pubitemid 26043830)
6. Morita Y, Tilly IL. Oocytic oophoritis: like sand through an hourglass. Dev Biol 1999; 213: 1-17. (Pubitemid 29409943)
7. Zuckerman S. The number of oocytes in the mature ovary. Recent Prog Horm Res 1951; 6: 63-108.
8. Johnson J, Canning J, Kaneko T, Pru SK, Tilly JL. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 2004; 428: 145-50. (Pubitemid 38374304)
9. Byskof AG, Faddy MJ, Lemmen JG, Andersen CY. Eggs forever? Differentiation 2005; 73: 438-46.
10. Liu Y, Wu C, Lyu Q, Yang D, Albertini DF, Keefe DL, et al. Germline stem cellls and neo-oogenesis in the adult human ovary. Dev Biol 2007; 306: 112-20. (Pubitemid 46809717)
11. Bukovsky A, Virant-Klun I, Svetlikova M, Willson I. Ovarian germ cells. Methods Enyzmol 2006; 419: 208-58. (Pubitemid 44820369)
12. Bukovsky A, Virant-Klun I. Adult stem cells in the human ovary. In: Carlos S, Pellicer A, eds. Stem cells in reproductive medicine: Basic science and therapeutic potential. London: Informa Healthcare; 2006. p. 53-69.
13. Duff GL, Bernstein C. Five cases of Addisons disease with socalled atrophy of the adrenal cortex. Bull Johns Hopkins Hospital 1933; 52: 637-40.
14. Bakalov VK, Vanderhoof VH, Body CA, Nelson LM. Adrenal autoantibodies detected asymptomatic auto-immune adrenal insufficiency in young women with spontaneus premature ovarian failure. Hum Reprod 2002; 17: 2096-100.
15. Betterle C, Volpato M. Adrenal and ovarian autoimmunity. Eur J Endocrinol 1998; 138: 16-25. (Pubitemid 28078804)
16. Dalpra C, Chen S, Furmaniak J. Autoantibodies to steroidogenic enyzmes in patients with premature ovarian failure and Addison's disease. Eur J Endocrinol 2003; 148: 565-70. (Pubitemid 36622165)
17. De Moraes-Ruehsen M, Blizzard RM, Garcia-Bunner R, Jones GS. Autoimmunity and ovarian failure. Am J Obstet Gynecol 1972; 112: 693-703.
18. Betterle C, Ross A, Dalla Pria S, Artifoni A. Premature ovarian failure: autoimmunity and natural history. Clin Endocrinol 1993; 39: 35-43. (Pubitemid 23212879)
19. Alper MM, Garner PR. Premature ovarian failure: its relationship to autoimmune disease. Obstet Gynecol 1985; 66: 27-30. (Pubitemid 15047378)
20. Forges T, Monnier-Barbarino P, Faure GC, Bene MC. Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Update 2004; 10: 163-75. (Pubitemid 38523297)
21. Irvine WJ. Premature menopause in autoimmune disease. Lancet 1969; 1: 565-70.
22. Valloton MB, Forbes AP. Antibodies to cytoplasm of ovary. Lancet 1966; 2: 264-5.
23. Ho PC, Tang GWK, Fu KH, Fan MC, Lawton WM. Immunologic studies in patients with premature ovarian failure. Obstet Gynecol 1988; 71: 622-6. (Pubitemid 18097652)
24. Damewood MD, Zacur HA, Hoffman GJ, Rock JA. Circulating antiovarian antibodies in premature ovarian failure. Obstet Gynecol 1986; 68: 850-4. (Pubitemid 17190230)
25. Coulam CB, Ryan RJ. Premature menopause. Etiology. Am J Obstet Gynecol 1979; 133: 639-43.
26. Coulam CB, Ryan RJ. Prevalence of circulating antibodies directed towards ovaries among women with premature ovarian failure. Am J Reprod Immunol Microbiol 1985; 9: 23-4. (Pubitemid 15250399)
27. Luborsky J, Llanes B, Davies S, Binor Z, Radwanska E, Pong R. Ovarian autoimmunity: greater frequency of autoantibodies in premature menopause and unexplained infertility than in the general population. Clin Immunol 1999; 90: 368-74. (Pubitemid 29159622)
28. Meyer W, Lavy G, De Cherney A, Visintin I. Evidence of gonadal and gonadotropin antibodies in woman with suboptimal ovarian response to exogenous gonadotropin. Obstet Gynecdol 1990; 75: 795-9. (Pubitemid 20139160)
29. Luborsky J, Pong R. Pregnancy outcome and ovarian autoimmunity in infertility patients undergoing controlled ovarian hyperstimulation. Am J Reprod Immunol 2000; 44: 261-5.
30. Luborsky J, Thiruppathi P, Rivany B. Evidence for different etiologies of low estradiol response to FSH: age-related accelerated luteinization of follicles of presence of ovarian autoantibodies. Hum Reprod 2002; 17: 2641-9. (Pubitemid 35174116)
31. Luborsky J. Ovarian autoimmune disease and aovarian autoantibodies: a review. J Womens Health Gender Based Med 2002; 11:585-99.
32. Mignot MH, Drexhage HA, Kleingeld M. Premature ovarian failure II. Considerations of cellular immunity defects. Eur J Obstet Gynecol Reprod Biol 1989; 30: 67-72. (Pubitemid 19022394)
33. Miyake T, Sato Y, Takeuchi S. Implications of circulating autoantibodies and peripheral blood lymphocyte subset for the genesis of premature ovarian failure. J Reprod Immunol 1987; 12: 163-71. (Pubitemid 18016474)
34. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-64.
35. Chernysmov VP, Radysh TV, Gura IV, Tatarshuk TP, Khominskaya ZB. Immune disorders in women with premature ovarian failure. Am J Reprod Immunol. 2001; 46: 220-5. (Pubitemid 32791427)
36. Ho PC, Tang GW, Lawton JW. Lymphocyte subsets and serum immunoglobulins in patients with premature ovarian failure before and after estrogen replacement. Hum Reprod 1993; 8: 714-6. (Pubitemid 23164287)
37. Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocrine Rev 1997; 11: 107-34. (Pubitemid 27076457)
38. Fanchin R, Schonauer LM, Righini C. Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH, LH on day 3. Hum Reprod 2003; 18: 323-7. (Pubitemid 36236265)
39. Van Rooij IA, Tonkelaar I, Broekmans FJ. Anti-Mullerian hormone is a promising predictor for the occurence of the menopausal transition. Menopause 2004; 11: 601-6. (Pubitemid 40353222)
40. Van Rooij IA, Broekmans FJ, Scheffer GJ. Serum anti mullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 2005; 83: 979-87.